Systemic lupus erythematosus CT: Difference between revisions

Jump to navigation Jump to search
Line 9: Line 9:
!Disease
!Disease
!CT
!CT
!SONO
|-
|-
| rowspan="6" |Gastrointestinal system
| rowspan="6" |Gastrointestinal system
Line 24: Line 23:
*** [[Pneumoperitoneum]] indicating perforation
*** [[Pneumoperitoneum]] indicating perforation
*** [[Bowel ischaemia]]
*** [[Bowel ischaemia]]
|
|-
|-
|[[Hepatitis]]
|[[Hepatitis]]
Line 31: Line 29:
* May present hepatic granulomas
* May present hepatic granulomas
** Discrete, sharply defined nodular lesions within the liver
** Discrete, sharply defined nodular lesions within the liver
|
|-
|-
|[[Acute pancreatitis]]
|[[Acute pancreatitis]]
Line 49: Line 46:
* [[Haemorrhage]]
* [[Haemorrhage]]
** High-attenuation fluid in the [[retroperitoneum]] or peripancreatic tissues
** High-attenuation fluid in the [[retroperitoneum]] or peripancreatic tissues
|
* to identify gallstones as a possible cause
* diagnosis of vascular complications, e.g. thrombosis
* identify areas of necrosis which appear as hypoechoic regions
|-
|-
|[[Autosplenectomy]]
|[[Autosplenectomy]]
Line 58: Line 51:
* Abnormally small and irregular splenic remnant
* Abnormally small and irregular splenic remnant
* May show calcified spleen
* May show calcified spleen
|Ultrasound will either not be able to demonstrate a spleen at all, or identify a small irregular and shadowing nodule in the splenic bed.
|-
|-
|[[Mesenteric vascular occlusion|Mesenteric vasculitis]]
|[[Mesenteric vascular occlusion|Mesenteric vasculitis]]
Line 71: Line 63:
** Hypervascular appearance of the [[mesentery]] 
** Hypervascular appearance of the [[mesentery]] 
** Linear densities on the mesenteric side of the affected segments of [[small bowel]], which lead to the appearance of the teeth of a comb 
** Linear densities on the mesenteric side of the affected segments of [[small bowel]], which lead to the appearance of the teeth of a comb 
|
|-
|-
|[[Acute cholecystitis]]
|[[Acute cholecystitis]]
Line 82: Line 73:
* Tensile gallbladder fundus sign
* Tensile gallbladder fundus sign
** Fundus bulging the anterior abdominal wall
** Fundus bulging the anterior abdominal wall
|
* gallbladder wall thickening (>3 mm) and pericholecystic fluid 
* Positive Murphy sign
* gallbladder distension
*
|-
|-
| rowspan="6" |Pulmonary involvement
| rowspan="6" |Pulmonary involvement
Line 93: Line 79:
* May be associated with thickening of the [[pleura]]
* May be associated with thickening of the [[pleura]]
* Fluid density
* Fluid density
|echo-free space between the visceral and parietal pleura
|-
|-
|[[Pulmonary emboli]]
|[[Pulmonary emboli]]
Line 119: Line 104:
** Focal ground-glass opacities
** Focal ground-glass opacities
** Bronchial anomalies
** Bronchial anomalies
|
|-
|-
|[[Pulmonary hypertension]]  
|[[Pulmonary hypertension]]  
Line 139: Line 123:
* Neovascularity
* Neovascularity
** Tiny serpiginous intrapulmonary vessels that often emerge from centrilobular arterioles but do not conform to usual [[Pulmonary artery|pulmonary arterial anatomy]]
** Tiny serpiginous intrapulmonary vessels that often emerge from centrilobular arterioles but do not conform to usual [[Pulmonary artery|pulmonary arterial anatomy]]
|
|-
|-
|Shrinking lung syndrome
|Shrinking lung syndrome
Line 146: Line 129:
* Occasional basal [[atelectasis]] 
* Occasional basal [[atelectasis]] 
* No major [[Interstitial lung disease|parenchymal lung]] or [[pleural disease]] 
* No major [[Interstitial lung disease|parenchymal lung]] or [[pleural disease]] 
|
|-
|-
|[[Pulmonary fibrosis]]
|[[Pulmonary fibrosis]]
Line 157: Line 139:
* Reticulation
* Reticulation
* Interlobular septal thickening
* Interlobular septal thickening
|
|-
|-
|[[Pneumonitis]]
|[[Pneumonitis]]
Line 163: Line 144:
* Unilateral or bilateral patchy and focal consolidation typically in the lung bases
* Unilateral or bilateral patchy and focal consolidation typically in the lung bases
* May accompany [[pleural effusion]]
* May accompany [[pleural effusion]]
|
|-
|-
| rowspan="4" |Cardiac involvement
| rowspan="4" |Cardiac involvement
Line 169: Line 149:
|
|
* Valve thickening or leaflet fixation
* Valve thickening or leaflet fixation
|
|-
|-
|[[Acute pericarditis]]
|[[Acute pericarditis]]
|
|
* Enhancement of the thickened [[pericardium]]
* Enhancement of the thickened [[pericardium]]
|
|-
|-
|[[Pericardial effusion]]
|[[Pericardial effusion]]
|
|
* Fluid density material surrounding the heart
* Fluid density material surrounding the heart
|Echocardiography is the method of choice to confirm the diagnosis, estimate the volume of fluid and most importantly assess the haemodynamic impact of the effusion
|-
|-
|[[Coronary heart disease|Coronary artery disease]]
|[[Coronary heart disease|Coronary artery disease]]
Line 185: Line 162:
* Coronary CT angiography (cCTA)
* Coronary CT angiography (cCTA)
** Show the amount of stenosis
** Show the amount of stenosis
|
|-
|-
| rowspan="2" |Neurological involvement
| rowspan="2" |Neurological involvement
Line 192: Line 168:
* Brain atrophy  
* Brain atrophy  
* May be due to steroid therapy or age  
* May be due to steroid therapy or age  
|
|-
|-
|[[Stroke]]
|[[Stroke]]
Line 203: Line 178:
** Cortical hypodensity with associated parenchymal swelling with resultant gyral effacement
** Cortical hypodensity with associated parenchymal swelling with resultant gyral effacement
** Elevation of the attenuation of the cortex
** Elevation of the attenuation of the cortex
|
|-
|
|Raynaud phenomen
|
|Doppler sonography:
flow volume and vessel size irregularities 
|}
|}



Revision as of 19:42, 17 July 2017

Systemic lupus erythematosus Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Systemic lupus erythematosus from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Lupus and Quality of Life

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Systemic lupus erythematosus CT On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Systemic lupus erythematosus CT

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

National Guidelines Clearinghouse

NICE Guidance

FDA on Systemic lupus erythematosus CT

on Systemic lupus erythematosus CT

Systemic lupus erythematosus CT in the news

Blogs onSystemic lupus erythematosus CT

Directions to Hospitals Treating Systemic lupus erythematosus

Risk calculators and risk factors for Systemic lupus erythematosus CT

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Organ Disease CT
Gastrointestinal system Intestinal pseudo-obstruction
  • Dilated bowel loops with or without the presence of fluid levels
    • A distinct transition point where bowel calibre changes from normal to abnormal
    • Dilated bowel loops proximal to the transition point
      • Small bowel >3.5 cm
      • Large bowel >5 cm
    • Collapsed or normal calibre bowel distal to the transitional point
    • Bowel wall thickening
    • Obstruction:
Hepatitis
  • Nonspecific, ranging from normal to hepatomegaly and cirrhosis
  • May present hepatic granulomas
    • Discrete, sharply defined nodular lesions within the liver
Acute pancreatitis Abnormalities that may be seen in the pancreas include:
  • Typical findings
    • Focal or diffuse parenchymal enlargement
    • Changes in density because of edema
    • Indistinct pancreatic margins owing to inflammation
    • Mesenteric fatty infiltration around the pancreas
  • Liquefactive necrosis of pancreatic parenchyma
    • Lack of parenchymal enhancement
    • Often multifocal
  • Abscess formation
    • Circumscribed fluid collection
    • Little or no necrotic tissues (thus distinguishing it from infected necrosis)
    • Phlegmon formation
  • Haemorrhage
Autosplenectomy
  • Abnormally small and irregular splenic remnant
  • May show calcified spleen
Mesenteric vasculitis
  • Ascites
    • Fluid in the abdomen 
  • Dilated bowel
  • Mural thickening
  • Abnormal wall enhancement
  • Mesentric vessel engorgement
  • Comb sign
    • Hypervascular appearance of the mesentery 
    • Linear densities on the mesenteric side of the affected segments of small bowel, which lead to the appearance of the teeth of a comb 
Acute cholecystitis
  • Gallbladder distension
  • Gallbladder wall thickening
  • Mural or mucosal hyperenhancement
  • Pericholecystic fluid and inflammatory fat stranding
  • Enhancement of the adjacent liver parenchyma due to reactive hyperaemia
  • Tensile gallbladder fundus sign
    • Fundus bulging the anterior abdominal wall
Pulmonary involvement Pleural effusion
  • May be associated with thickening of the pleura
  • Fluid density
Pulmonary emboli
  • Filling defects within the pulmonary vasculature with acute pulmonary emboli
  • Vascular CT signs include
    • Direct pulmonary artery signs
      • Complete obstruction
      • Partial obstruction
      • Eccentric thrombus
      • Calcified thrombus- calcific pulmonary emboli
      • Pulmonary arterial bands
      • Post stenotic dilatation
    • Signs related to pulmonary hypertension
    • Signs of systemic collateral supply
      • Enlargement of bronchial and nonbronchial systemic arteries
  • Parenchymal signs (often non-specific on their own)
    • Scars
    • Mosaic perfusion pattern
    • Focal ground-glass opacities
    • Bronchial anomalies
Pulmonary hypertension
  • Enlarged pulmonary trunk (measured at pulmonary artery bifurcation on an axial slice vertical to its long axis)
  • Enlarged pulmonary arteries
  • Mural calcification in central pulmonary arteries
  • Centrilobular ground-glass nodules
  • Neovascularity
    • Tiny serpiginous intrapulmonary vessels that often emerge from centrilobular arterioles but do not conform to usual pulmonary arterial anatomy
Shrinking lung syndrome
Pulmonary fibrosis
  • Honeycombing
    • Fibrotic cystic changes
  • Traction bronchiectasis
  • Lung architectural distortion
  • Reticulation
  • Interlobular septal thickening
Pneumonitis
  • Unilateral or bilateral patchy and focal consolidation typically in the lung bases
  • May accompany pleural effusion
Cardiac involvement Mitral stenosis
  • Valve thickening or leaflet fixation
Acute pericarditis
Pericardial effusion
  • Fluid density material surrounding the heart
Coronary artery disease
  • Coronary CT angiography (cCTA)
    • Show the amount of stenosis
Neurological involvement Genreral
  • Brain atrophy
  • May be due to steroid therapy or age
Stroke
  • Early sign
    • A hyperdense segment of a vessel, representing direct visualisation of the intravascular thrombus
  • Early hyperacute
    • Loss of grey-white matter differentiation
    • Hypoattenuation of deep nuclei
    • Cortical hypodensity with associated parenchymal swelling with resultant gyral effacement
    • Elevation of the attenuation of the cortex

Key CT Findings in Systemic Lupus Erythematosus

Examples of CT Findings in Systemic Lupus Erythematosus

References

Template:WH Template:WS